BamSEC and AlphaSense Join Forces
Learn More

Spectrum Pharmaceuticals, Inc.

Formerly NASDAQ: SPPI
Search in Documents
Key Exhibits
External Links

Plans of Reorganization, Merger, Acquisition or Similar Filter

EX-2.1
from DEFA14A 143 pages Agreement and Plan of Merger Among Assertio Holdings, Inc. Spade Merger Sub 1, Inc. and Spectrum Pharmaceuticals, Inc. Dated as of April 24, 2023
12/34/56
EX-2.1
from 8-K 143 pages Agreement and Plan of Merger Among Assertio Holdings, Inc. Spade Merger Sub 1, Inc. and Spectrum Pharmaceuticals, Inc. Dated as of April 24, 2023
12/34/56
EX-2.1
from 425 143 pages Agreement and Plan of Merger Among Assertio Holdings, Inc. Spade Merger Sub 1, Inc. and Spectrum Pharmaceuticals, Inc. Dated as of April 24, 2023
12/34/56
EX-2.1
from 10-Q 3 pages Amendment to License and Asset Purchase Agreement
12/34/56
EX-2.4
from 8-K 33 pages Exchange Agreement
12/34/56
EX-2.3
from 8-K 20 pages Contingent Value Rights Agreement
12/34/56
EX-2.2
from 8-K 55 pages Stock Purchase Agreement by and Among Spectrum Pharmaceuticals, Inc., Talon Therapeutics, Inc. and Eagle Acquisition Merger Sub, Inc. July 16, 2013
12/34/56
EX-2.1
from 8-K 23 pages Securities Purchase Agreement by and Among Spectrum Pharmaceuticals, Inc. Eagle Acquisition Merger Sub, Inc. and the Securityholders of Talon Therapeutics, Inc. Named Herein July 16, 2013
12/34/56
EX-2.1
from 10-Q 117 pages Confidential License and Asset Purchase Agreement Dated as of January 23, 2012 Between Spectrum Pharmaceuticals Cayman, L.P. and Bayer Pharma AG
12/34/56
EX-2.3
from SC TO-C 14 pages Tender and Voting Agreement
12/34/56
EX-2.3
from 8-K 14 pages Tender and Voting Agreement
12/34/56
EX-2.2
from 8-K 13 pages Contingent Value Rights Agreement
12/34/56
EX-2.2
from SC TO-C 13 pages Contingent Value Rights Agreement
12/34/56
EX-2.1
from SC TO-C 94 pages Agreement and Plan of Merger Among: Spectrum Pharmaceuticals, Inc., a Delaware Corporation; Sapphire Acquisition Sub, Inc., a Delaware Corporation; and Allos Therapeutics, Inc., a Delaware Corporation Dated as of April 4, 2012
12/34/56
EX-2.1
from 8-K 94 pages Agreement and Plan of Merger Among: Spectrum Pharmaceuticals, Inc., a Delaware Corporation; Sapphire Acquisition Sub, Inc., a Delaware Corporation; and Allos Therapeutics, Inc., a Delaware Corporation Dated as of April 4, 2012
12/34/56
EX-2.1
from 10-Q 13 pages Limited Liability Company Interest Assignment Agreement
12/34/56
EX-2.1
from 8-K 48 pages Purchase and Formation Agreement
12/34/56
EX-2.1
from 10-Q 27 pages Asset Purchase Agreement Between Spectrum Pharmaceuticals, Inc. and Par Pharmaceutical, Inc. Dated as of May 6, 2008
12/34/56
EX-2.1
from 10-K/A 64 pages Asset Purchase Agreement by and Between Targent Inc. as Seller, Certain Stockholders of Seller, and Spectrum Pharmaceuticals, Inc. as Purchaser Dated as of March 17, 2006
12/34/56